Unichem Laboratories Ltd sells 1st tranche of stake in Optimus for Rs. 270.98 crores

Unichem Laboratories Ltd has announced that the sale of 19.97% equity shares in Optimus Drugs Private Limited ("Optimus") to Sekhmet Pharmaventures Private Limited ("Purchaser"), was completed on September 22, 2022 and it has received payment towards completion of sale of first tranche.

For the first tranche the company has received INR 270,98,99,010. For the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent.

Incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.

Source : Equity Bulls

Keywords

UnichemLaboratories StakeSale OptimusDrugs SekhmetPharmaventures